These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease. Chuo LJ; Sheu WH; Pai MC; Kuo YM Dement Geriatr Cogn Disord; 2007; 23(4):251-7. PubMed ID: 17310123 [TBL] [Abstract][Full Text] [Related]
4. Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099 [TBL] [Abstract][Full Text] [Related]
5. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease. Helisalmi S; Väkevä A; Hiltunen M; Soininen H Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004 [TBL] [Abstract][Full Text] [Related]
7. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study. Babiloni C; Benussi L; Binetti G; Bosco P; Busonero G; Cesaretti S; Dal Forno G; Del Percio C; Ferri R; Frisoni G; Ghidoni R; Rodriguez G; Squitti R; Rossini PM Neuroimage; 2006 Feb; 29(3):948-64. PubMed ID: 16213753 [TBL] [Abstract][Full Text] [Related]
8. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028 [TBL] [Abstract][Full Text] [Related]
9. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease. Cui T; Zhou X; Jin W; Zheng F; Cao X Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232 [TBL] [Abstract][Full Text] [Related]
10. Association analysis of the paraoxonase-1 gene with Alzheimer's disease. Cellini E; Tedde A; Bagnoli S; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S Neurosci Lett; 2006 Nov; 408(3):199-202. PubMed ID: 16996683 [TBL] [Abstract][Full Text] [Related]
11. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese. Bian JT; Zhang JW; Zhang ZX; Zhao HL Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753 [TBL] [Abstract][Full Text] [Related]
12. [An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population]. Wu YN; Zhang JW; Zhang ZX; Qu QM; Chen D Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):450-4. PubMed ID: 12905860 [TBL] [Abstract][Full Text] [Related]
13. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease. Beyer K; Lao JI; Latorre P; Ariza A Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900 [TBL] [Abstract][Full Text] [Related]
14. [Analysis on association between the polymorphisms in apolipoprotein E, interleukin-1 alpha genes and Alzheimer's disease in Chengdu area]. Tang MN; Zhang ZX; Han HY; Liu XH; Shen Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):176-8. PubMed ID: 15079806 [TBL] [Abstract][Full Text] [Related]
15. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms. Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809 [TBL] [Abstract][Full Text] [Related]
16. No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population. Monastero R; Camarda C; Cefalù AB; Caldarella R; Camarda LK; Noto D; Averna MR; Camarda R J Alzheimers Dis; 2005 Aug; 7(4):291-5. PubMed ID: 16131730 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype in patients with Alzheimer's disease. Luo B; Chen Z; Zhang Y; Pan X; Li X; Chen F Chin Med J (Engl); 2003 Aug; 116(8):1220-2. PubMed ID: 12935416 [TBL] [Abstract][Full Text] [Related]
18. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease. Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094 [TBL] [Abstract][Full Text] [Related]
19. Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease. Nacmias B; Tedde A; Bagnoli S; Cellini E; Guarnieri BM; Piacentini S; Sorbi S J Alzheimers Dis; 2009; 16(3):513-5. PubMed ID: 19276544 [TBL] [Abstract][Full Text] [Related]
20. Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms. Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Bifaro L; Menga R; Santamato A; Seripa D; Pilotto A; Capurso A; Panza F Neurosci Lett; 2008 Feb; 432(3):237-42. PubMed ID: 18248894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]